Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Magbanua, Mark J M ^a   Sosa, Eduardo V ^a   Scott, Janet H ^a   Simko, Jeff ^b,d   Collins, Colin ^c   Pinkel, Dan ^b,d   Ryan, Charles J ^a,d   Park, John W ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen receptor; Array comparative genomic hybridization; Castration resistant prostate cancer; Circulating tumor cells; Copy number analysis

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; CELL ISOLATION; CELL LINEAGE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENRICHMENT CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE DOSAGE; GENE LOCUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMAGNETIC SEPARATION; MALE; METASTASIS POTENTIAL; OVERALL SURVIVAL; PROCESS OPTIMIZATION; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PATHOLOGY; PILOT STUDY; PROSTATE TUMOR; TUMOR EMBOLISM;

CYTOLOGICAL TECHNIQUES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 84862782971     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-78     Document Type: Article

References (38)

1. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4(6):448-456. 10.1038/nrc1370, 15170447.
2. Cristofanilli M, Mendelsohn J. Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?. Proc Natl Acad Sci USA 2006, 103(46):17073-17074. 10.1073/pnas.0608651103, 1859890, 17090687.
3. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8(5):329-340. 10.1038/nrc2375, 18404148.
4. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23(7):1420-1430. 10.1200/JCO.2005.08.140, 15735118.
5. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351(8):781-791. 10.1056/NEJMoa040766, 15317891.
6. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008, 14(19):6302-6309. 10.1158/1078-0432.CCR-08-0872, 18829513.
7. Waldman FM, DeVries S, Chew KL, Moore DH, Kerlikowske K, Ljung BM. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000, 92(4):313-320. 10.1093/jnci/92.4.313, 10675380.
8. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007, 13(23):7053-7058. 10.1158/1078-0432.CCR-07-1506, 18056182.
9. Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D, et al. Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 2004, 32(9):e71. 10.1093/nar/gnh069, 419624, 15150323.
10. Devries S, Nyante S, Korkola J, Segraves R, Nakao K, Moore D, Bae H, Wilhelm M, Hwang S, Waldman F. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn 2005, 7(1):65-71. 10.1016/S1525-1578(10)60010-4, 1867501, 15681476.
11. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999, 96(8):4494-4499. 10.1073/pnas.96.8.4494, 16360, 10200290.
12. Fiegler H, Geigl JB, Langer S, Rigler D, Porter K, Unger K, Carter NP, Speicher MR. High resolution array-CGH analysis of single cells. Nucleic Acids Res 2007, 35(3):e15. 10.1093/nar/gkl1030, 1807964, 17178751.
13. Geigl JB, Speicher MR. Single-cell isolation from cell suspensions and whole genome amplification from single cells to provide templates for CGH analysis. Nat Protoc 2007, 2(12):3173-3184. 10.1038/nprot.2007.476, 18079717.
14. Nowak NJ, Miecznikowski J, Moore SR, Gaile D, Bobadilla D, Smith DD, Kernstine K, Forman SJ, Mhawech-Fauceglia P, Reid M, et al. Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med 2007, 9(9):585-595. 10.1097/GIM.0b013e3181461c4a, 17873646.
15. Fuhrmann C, Schmidt-Kittler O, Stoecklein NH, Petat-Dutter K, Vay C, Bockler K, Reinhardt R, Ragg T, Klein CA. High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Res 2008, 36(7):e39. 10.1093/nar/gkn101, 2367728, 18344524.
16. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001, 29(3):263-264. 10.1038/ng754, 11687795.
17. Hamilton G, Brown N, Oseroff V, Huey B, Segraves R, Sudar D, Kumler J, Albertson D, Pinkel D. A large field CCD system for quantitative imaging of microarrays. Nucleic Acids Res 2006, 34(8):e58. 10.1093/nar/gkl160, 1456328, 16670425.
18. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. Fully automatic quantification of microarray image data. Genome Res 2002, 12(2):325-332. 10.1101/gr.210902, 155276, 11827952.
19. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5(4):557-572. 10.1093/biostatistics/kxh008, 15475419.
20. Liu W, Xie CC, Zhu Y, Li T, Sun J, Cheng Y, Ewing CM, Dalrymple S, Turner AR, Isaacs JT, et al. Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia 2008, 10(8):897-907. 2481576, 18670647.
21. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20(2):207-211. 10.1038/2524, 9771718.
22. Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Isaacs WB, et al. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate 2007, 67(7):692-700. 10.1002/pros.20543, 17342750.
23. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999, 59(4):803-806.
24. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995, 9(4):401-406. 10.1038/ng0495-401, 7795646.
25. Jiang Y, Palma JF, Agus DB, Wang Y, Gross ME. Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clin Chem 2010, 56(9):1492-1495. 10.1373/clinchem.2010.143297, 20581083.
26. Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama JW, Sleijfer S, Foekens JA. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat 2009, 118(3):455-468. 10.1007/s10549-008-0290-0, 19115104.
27. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005, 65(12):4993-4997. 10.1158/0008-5472.CAN-04-4330, 15958538.
28. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998, 95(8):4589-4594. 10.1073/pnas.95.8.4589, 22534, 9539782.
29. Scher HI, Sawyers CL. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005, 23(32):8253-8261. 10.1200/JCO.2005.03.4777, 16278481.
30. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009, 15(5):559-565. 10.1038/nm.1944, 2839160, 19363497.
31. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JW, Gratama JW, Sleijfer S, Foekens JA. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009, 101(1):61-66. 2639293, 19116383.
32. Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, A'Hern R, Levink R, Coumans F, Moreira J, Riisnaes R, et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009, 69(7):2912-2918. 10.1158/0008-5472.CAN-08-3667, 19339269.
33. Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res 2009, 15(6):2091-2097. 10.1158/1078-0432.CCR-08-2036, 2875199, 19276271.
34. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010, 2(25):25ra23. 10.1126/scitranslmed.3000403, 3141292, 20424012.
35. Holcomb IN, Grove DI, Kinnunen M, Friedman CL, Gallaher IS, Morgan TM, Sather CL, Delrow JJ, Nelson PS, Lange PH, et al. Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Res 2008, 68(14):5599-5608. 10.1158/0008-5472.CAN-08-0812, 2613025, 18632612.
36. Weckermann D, Polzer B, Ragg T, Blana A, Schlimok G, Arnholdt H, Bertz S, Harzmann R, Klein CA. Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. J Clin Oncol 2009, 27(10):1549-1556. 10.1200/JCO.2008.17.0563, 19237635.
37. Wiedswang G, Borgen E, Schirmer C, Karesen R, Kvalheim G, Nesland JM, Naume B. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer 2006, 118(8):2013-2019. 10.1002/ijc.21576, 16287086.
38. Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S, Fan T, Adler HL, Yera ER, Zarrabi MH, Zucker S, et al. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett 2009, 277(2):164-173. 10.1016/j.canlet.2008.12.007, 19162393.